- Home
- KRMD vs OXLCO Comparison
KRMD vs OXLCO Comparison
Compare KRMD & OXLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- OXLCO
- Stock Information
- Founded
- KRMD 1980
- OXLCO N/A
- Country
- KRMD United States
- OXLCO United States
- Employees
- KRMD N/A
- OXLCO N/A
- Industry
- KRMD Medical/Dental Instruments
- OXLCO Investment Managers
- Sector
- KRMD Health Care
- OXLCO Finance
- Exchange
- KRMD Nasdaq
- OXLCO Nasdaq
- Market Cap
- KRMD 113.5M
- OXLCO N/A
- IPO Year
- KRMD N/A
- OXLCO N/A
- Fundamental
- Price
- KRMD $2.24
- OXLCO $22.58
- Analyst Decision
- KRMD Strong Buy
- OXLCO
- Analyst Count
- KRMD 4
- OXLCO 0
- Target Price
- KRMD $4.88
- OXLCO N/A
- AVG Volume (30 Days)
- KRMD 151.2K
- OXLCO N/A
- Earning Date
- KRMD 05-07-2025
- OXLCO N/A
- Dividend Yield
- KRMD N/A
- OXLCO N/A
- EPS Growth
- KRMD N/A
- OXLCO N/A
- EPS
- KRMD N/A
- OXLCO N/A
- Revenue
- KRMD $33,646,463.00
- OXLCO N/A
- Revenue This Year
- KRMD $16.50
- OXLCO N/A
- Revenue Next Year
- KRMD $15.47
- OXLCO N/A
- P/E Ratio
- KRMD N/A
- OXLCO N/A
- Revenue Growth
- KRMD 17.98
- OXLCO N/A
- 52 Week Low
- KRMD $1.86
- OXLCO N/A
- 52 Week High
- KRMD $5.05
- OXLCO N/A
- Technical
- Relative Strength Index (RSI)
- KRMD 34.73
- OXLCO 44.03
- Support Level
- KRMD $2.08
- OXLCO $22.28
- Resistance Level
- KRMD $2.53
- OXLCO $22.65
- Average True Range (ATR)
- KRMD 0.22
- OXLCO 0.07
- MACD
- KRMD 0.04
- OXLCO -0.01
- Stochastic Oscillator
- KRMD 52.78
- OXLCO 44.78
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
About OXLCO Oxford Lane Capital Corp. Preferred Stock Shares 6.00% Series 2029
Oxford Lane Capital Corp is a non-diversified closed-end management investment company. The fund's investment objective is to maximize its portfolio's risk-adjusted total return over its investment horizon. Its current focus is to seek that return by investing in equity and junior tranches of CLO(collateralized loan obligation) vehicles, which are collateralized by a diverse portfolio of senior loans, and which generally have little to no exposure to real estate loans, mortgage loans or pools of consumer-based debt, such as credit card receivables or auto loans. Its investment plan also includes investing in warehouse facilities, which are financing structures intended to aggregate senior loans that may be used to form the basis of a CLO vehicle.